heart disease

by The University of Hong Kong edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Karolina Grabowska from Pexels A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk prediction […]

by European Society of Cardiology edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Examples of mammograms showing mild, moderate and severe calcification. Credit: European Heart Journal / Hari Trivedi The risk of serious or fatal heart disease can be predicted with artificial intelligence (AI) analysis of mammograms, according to research published in

More than half of people with advanced kidney disease develop cardiovascular problems. A new study finds that diseased kidneys release tiny particles that are toxic to the heart. February 1, 2026 at 5:00 a.m. ESTYesterday at 5:00 a.m. EST 5 min Make us preferred on Google (Washington Post illustration; iStock) By Allyson Chiu For years, scientists

by Céline Gravot-Schüppel, Helmholtz Association of German Research Centres edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source fRSOM procedure to assess skin microvasculature endothelial function. Credit: Light: Science & Applications (2026). DOI: 10.1038/s41377-025-02103-6 Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM,” a new imaging technology that

Peer-Reviewed Publication Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)) Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for invasive procedures. By revealing

by Vanderbilt University Medical Center edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: Pixabay/CC0 Public Domain About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). A study by Vanderbilt Health researchers reveals that it puts them at

by Mary J. Scourboutakos, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes Credit: Unsplash/CC0 Public Domain Heart disease is the leading cause of death in the United States. Since researchers first established the link between diet, cholesterol and heart disease in the 1950s, risk for heart disease has been partly assessed based on a patient’s cholesterol

by Technion – Israel Institute of Technology edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes Credit: JACC: CardioOncology (2025). DOI: 10.1016/j.jaccao.2025.04.007 A surprising new discovery by Prof. Ami Aronheim and his team at the Technion–Israel Institute of Technology shows that in the absence of anti-cancer treatments, cancer development may actually improve heart function and reduce fibrosis—the scarring process